Vimarsana
Biggest News Aggregation in the World

Page 3 - Surmodics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Surmodics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Surmodics Inc Today - Breaking & Trending Today

SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating - Vimarsana News

SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating

We are investigating the fairness of the sale of Surmodics to GTCR for $43.00 per share in cash...

Surmodics Going Private in $627M Deal | Twin Cities Business - Vimarsana News

Surmodics Going Private in $627M Deal | Twin Cities Business

Chicago private equity firm GTCR has inked a deal to buy the Eden Prairie-based medtech company Surmodics Inc.

Source: tcbmag.com
Surmodics' (SRDX) "Hold" Rating Reaffirmed at Lake Street Capital - Vimarsana News

Surmodics' (SRDX) "Hold" Rating Reaffirmed at Lake Street Capital

Surmodics (NASDAQ:SRDX – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Lake Street Capital in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $43.00 target price on the stock. Lake Street Capital’s price target points to a potential upside of 2.14% from the company’s […]

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc. - Vimarsana News

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.

NEW YORK, May 29, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Surmodics, Inc. and its board of directors concerning the proposed acquisition of the...

Top Midday Gainers - Vimarsana News

Top Midday Gainers

-- Surmodics reported Wednesday a swing to earnings in fiscal Q2 as sales jumped more than forecast. Shares jumped 31% as intraday trading volume climbed to more than 127,000 versus the stock's...

Related Topics:
Surmodics IncMedical Device